PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and ...

SynCardia Systems will work with design firm Hydrix on the development of the Emperor, a next-gen, fully implantable Total ...

Picard Medical, Inc. (NYSE American: PMI) ('Picard” or the 'Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...

Hydrix secures a $2.5m deal with SynCardia to collaborate on Emperor total artificial heart tech, launching a multi-stage development program. HYD inks $2.5m deal with SynCardia on Emperor.

All SynCardia sales and clinical staff have completed the required training in advance of the rollout. SynCardia will work directly with hospital and clinical teams to provide training materials, ...

Picard Medical, Inc. (NYSE American: PMI) ("Picard" or the "Company"), parent company of SynCardia Systems, LLC, maker of the world's first total artificial ...

Picard Medical (PMI) announced that it would begin to incorporate an additional design component of an FDA-cleared accessory, CPC1 “Connector ...

The 50cc total artificial heart. [Image from the SynCardia website] Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced today that it plans to launch a new, ...